Market revenue in 2024 | USD 51,588.0 million |
Market revenue in 2030 | USD 52,615.3 million |
Growth rate | 0.8% (CAGR from 2025 to 2030) |
Largest segment | Antibacterials |
Fastest growing segment | Antifungals |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Antibacterials, Antivirals, Antifungals |
Key market players worldwide | Pfizer Inc, Abbott Laboratories, Gilead Sciences Inc, Bristol-Myers Squibb Co, Merck & Co Inc, Sandoz Group AG ADR, B. Braun, Novo Holdings, Mankind Pharma, Bayer AG, AstraZeneca PLC, Boehringer Ingelheim Pharma |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anti-infective agents market will help companies and investors design strategic landscapes.
Antibacterials was the largest segment with a revenue share of 74.4% in 2024. Horizon Databook has segmented the North America anti-infective agents market based on antibacterials, antivirals, antifungals covering the revenue growth of each sub-segment from 2018 to 2030.
The North America anti-infective agents market is experiencing steady growth, driven by rising cases of infectious diseases, hospital-acquired infections, and a growing elderly population susceptible to infections. HIV.gov reports that approximately 31,800 people acquired HIV in the U.S. in 2022.
Additionally, in the same year, 37,981 individuals aged 13 and older received an HIV diagnosis across the U.S., including its six territories and freely associated states. Innovations in the field, especially in response to antibiotic resistance, have spurred demand for new antibiotics, antifungals, antivirals, and other anti-infective treatments.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America anti-infective agents market , including forecasts for subscribers. This continent databook contains high-level insights into North America anti-infective agents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account